Bruce J. Dolnick

1.5k total citations
46 papers, 1.2k citations indexed

About

Bruce J. Dolnick is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Bruce J. Dolnick has authored 46 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 14 papers in Oncology and 6 papers in Rheumatology. Recurrent topics in Bruce J. Dolnick's work include Biochemical and Molecular Research (19 papers), Colorectal Cancer Treatments and Studies (13 papers) and Molecular Biology Techniques and Applications (6 papers). Bruce J. Dolnick is often cited by papers focused on Biochemical and Molecular Research (19 papers), Colorectal Cancer Treatments and Studies (13 papers) and Molecular Biology Techniques and Applications (6 papers). Bruce J. Dolnick collaborates with scholars based in United States and Taiwan. Bruce J. Dolnick's co-authors include Y. C. Cheng, L. James Maher, John J. Pink, Cindy L. Will, Joseph R. Bertino, Shin-Lian Doong, Robert Schimke, Ronald Berenson, Jack H. Nunberg and Adrian R. Black and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Bruce J. Dolnick

46 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce J. Dolnick United States 22 944 337 161 130 103 46 1.2k
Sumiko Kaneda Japan 16 816 0.9× 339 1.0× 114 0.7× 119 0.9× 105 1.0× 30 1.1k
Charles Garrett United States 9 1.2k 1.3× 209 0.6× 56 0.3× 97 0.7× 146 1.4× 10 1.5k
Ming Chu United States 17 678 0.7× 259 0.8× 52 0.3× 112 0.9× 70 0.7× 49 1.2k
R. Gitendra Wickremasinghe United Kingdom 24 918 1.0× 353 1.0× 49 0.3× 138 1.1× 91 0.9× 54 1.7k
P.K. Chiang United States 11 558 0.6× 165 0.5× 175 1.1× 126 1.0× 38 0.4× 25 977
Priya Chaturvedi United States 13 1.0k 1.1× 934 2.8× 47 0.3× 259 2.0× 111 1.1× 13 1.8k
Sandra Grau United Kingdom 8 702 0.7× 136 0.4× 92 0.6× 63 0.5× 58 0.6× 10 1.2k
Yantao He United States 22 1.2k 1.3× 283 0.8× 63 0.4× 71 0.5× 187 1.8× 42 1.9k
Benjamin T. Vroman United States 20 1.1k 1.1× 732 2.2× 34 0.2× 131 1.0× 168 1.6× 24 1.8k
Yun Liang China 17 597 0.6× 185 0.5× 88 0.5× 146 1.1× 72 0.7× 36 1.2k

Countries citing papers authored by Bruce J. Dolnick

Since Specialization
Citations

This map shows the geographic impact of Bruce J. Dolnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce J. Dolnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce J. Dolnick more than expected).

Fields of papers citing papers by Bruce J. Dolnick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce J. Dolnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce J. Dolnick. The network helps show where Bruce J. Dolnick may publish in the future.

Co-authorship network of co-authors of Bruce J. Dolnick

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce J. Dolnick. A scholar is included among the top collaborators of Bruce J. Dolnick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce J. Dolnick. Bruce J. Dolnick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ko, Pin‐Joe, Blake Carrington, Raman Sood, et al.. (2011). Transient knockdown and overexpression reveal a developmental role for the zebrafish enosf1b gene. Cell & Bioscience. 1(1). 32–32. 12 indexed citations
2.
Dolnick, Bruce J.. (2005). The rTS Signaling Pathway as a Target for Drug Development. Clinical Colorectal Cancer. 5(1). 57–60. 7 indexed citations
3.
Liang, Ping, Jayakumar R. Nair, Lei Song, John J. McGuire, & Bruce J. Dolnick. (2005). Comparative genomic analysis reveals a novel mitochondrial isoform of human rTS protein and unusual phylogenetic distribution of the rTS gene. BMC Genomics. 6(1). 125–125. 7 indexed citations
4.
Dolnick, Bruce J., et al.. (2003). A Novel Function for the rTS gene. Cancer Biology & Therapy. 2(4). 364–369. 27 indexed citations
5.
Wu, Qi & Bruce J. Dolnick. (2003). Detection of Thymidylate Synthase Modulators by a Novel Screening Assay. Molecular Pharmacology. 63(1). 167–173. 8 indexed citations
6.
Dolnick, Bruce J., et al.. (2002). Natural antisense (rTSα) RNA induces site-specific cleavage of thymidylate synthase mRNA. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1587(2-3). 183–193. 36 indexed citations
7.
Dolnick, Bruce J.. (2000). Regulation of thymidylate synthase mRNA levels by RNA editing. 41. 148. 2 indexed citations
8.
Berleth, Erica S., et al.. (1999). Measurement of low-abundance cytokine mRNA in cells of murine lymphoid organs: a new quantitative reverse transcription/polymerase chain reaction method. Cancer Immunology Immunotherapy. 48(8). 471–481. 2 indexed citations
9.
Dolnick, Bruce J., et al.. (1997). Recent advances in the study of rTS proteins. rTS expression during growth and in response to thymidylate synthase inhibitors in human tumor cells. Advances in Enzyme Regulation. 37. 95–109. 14 indexed citations
10.
Dolnick, Bruce J.. (1997). Naturally occurring antisense RNA. Pharmacology & Therapeutics. 75(3). 179–184. 28 indexed citations
11.
Berleth, Erica S., Bruce J. Dolnick, M. Jane Ehrke, & Enrico Mihich. (1994). RNA recovery efficiency for cultured cells and organ-derived cell suspensions. Nucleic Acids Research. 22(10). 1925–1927. 1 indexed citations
12.
Baker, Raymond M., et al.. (1994). Subclonal heterogeneity of the multidrug resistance phenotype in a cell line expressing antisense MDR1 RNA. Somatic Cell and Molecular Genetics. 20(6). 463–480. 5 indexed citations
13.
Hsueh, Chung-Tsen & Bruce J. Dolnick. (1994). Regulation of folate-binding protein gene expression by DNA methylation in methotrexate-resistant KB cells. Biochemical Pharmacology. 47(6). 1019–1027. 26 indexed citations
14.
Dolnick, Bruce J.. (1993). Cloning and characterization of a naturally occurring antisense RNA to human thymidylate synthase mRNA. Nucleic Acids Research. 21(8). 1747–1752. 45 indexed citations
15.
Dolnick, Bruce J., et al.. (1993). Effects of 5-Fluorouracil on mRNA. Advances in experimental medicine and biology. 339. 57–65. 3 indexed citations
16.
Wang, Sijian & Bruce J. Dolnick. (1993). Quantitative evaluation of intracellular sense: antisense RNA hybrid deuplexes. Nucleic Acids Research. 21(18). 4383–4391. 34 indexed citations
17.
Dolnick, Bruce J.. (1991). New Drugs: Antisense Agents in Cancer Research and Therapeutics. Cancer Investigation. 9(2). 185–194. 38 indexed citations
18.
Dolnick, Bruce J.. (1990). Antisense agents in pharmacology. Biochemical Pharmacology. 40(4). 671–675. 33 indexed citations
19.
Maher, L. James & Bruce J. Dolnick. (1988). Comparative hybrid arrest by tandem antisense oligodeoxyribonucleotides or oligodeoxyribonucleoside methylpbosphonates in a cell-free system. Nucleic Acids Research. 16(8). 3341–3358. 99 indexed citations
20.
Rode, Wojciech, Bruce J. Dolnick, & Joseph R. Bertino. (1980). Isolation of a homogeneous preparation of human thymidylate synthetase from HeLa cells. Biochemical Pharmacology. 29(5). 723–726. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sumiko Kaneda Breakdown of academic impact, for papers by Charles Garrett Breakdown of academic impact, for papers by Ming Chu Breakdown of academic impact, for papers by R. Gitendra Wickremasinghe Breakdown of academic impact, for papers by P.K. Chiang Breakdown of academic impact, for papers by Priya Chaturvedi Breakdown of academic impact, for papers by Sandra Grau Breakdown of academic impact, for papers by Yantao He Breakdown of academic impact, for papers by Benjamin T. Vroman Breakdown of academic impact, for papers by Yun Liang
Rankless by CCL
2026